VCF yields 155.52% · PFE yields 6.20%● Live data
📍 VCF pulled ahead of the other in Year 1
Combined, VCF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VCF + PFE for your $10,000?
Delaware Investments Colorado Municipal Income Fund, Inc. is a closed-ended fixed income mutual fund launched by Delaware Management Holdings, Inc. It is managed by Delaware Management Business Trust. The fund invests in the fixed income markets of the United States. It primarily invests in un-insured, investment grade, tax-exempt Colorado municipal obligations, including airport revenue bonds, city general obligation bonds, continuing care/retirement revenue bonds, convention center/auditorium/hotel revenue bonds, dedicated tax and fees revenue bonds, higher education revenue bonds, hospital revenue bonds, municipal lease revenue bonds, parking revenue bonds, political subdivision general obligation bonds, pre-refunded bonds, school district general obligation bonds, school district revenue bonds, turnpike/toll road revenue bonds, and water and sewer revenue bonds. The fund seeks to maintain an average portfolio maturity of 20 to 30 years. It benchmarks the performance of its portfolio against the Barclays Municipal Bond Index and Lipper CE Other States Municipal Debt Funds Average. Delaware Investments Colorado Insured Municipal Income Fund, Inc. was formed on July 29, 1993 and is domiciled in the United States.
Full VCF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.